AIxCrypto Holdings, Inc. — fact timeline

AIxCrypto Holdings, Inc. entered into Purchase Agreement with Gold King Arthur Holding Limited valued at $50,000,000 (effective 2026-06-16).

“On June 16, 2026, AIxCrypto Holdings, Inc., a Delaware corporation (the “Company”) entered into a common shares purchase agreement (the “Purchase Agreement”) with Gold King Arthur Holding Limited, a Hong Kong limited liability company (the “Purchaser”) pursuant to which the Company agreed to sell and issue to the Purchaser in a private placement offering (the “Offering”) up to the lesser of (i) $50,000,000 in aggregate gross purchase price of duly authorized, validly issued, fully paid and non-assessable shares of common stock of the Company, par value $0.001 per share (the “Common Shares”) and (ii) 19.99% of the voting power of the Common Shares issued and outstanding immediately prior to the execution of the Purchase Agreement (the “Exchange Cap”), as adjusted pursuant to the terms of the Purchase Agreement.”

Jerry Wang was appointed as director at AIxCrypto Holdings, Inc..

“On May 21, 2026, the Board appointed Jerry Wang to serve as a director of the Company, effective immediately.”

Jie (Jay) Sheng was appointed as President and Chief Financial Officer at AIxCrypto Holdings, Inc..

“On May 21, 2026, the Board appointed Jie (Jay) Sheng, current independent director of the Company, as President, and as Chief Financial Officer, effective June 21, 2026.”

Campbell Becher resigned as President at AIxCrypto Holdings, Inc..

“On May 21, 2026, Campbell Becher resigned from his position as President of the Company, effective immediately.”

Koti Meka resigned as director at AIxCrypto Holdings, Inc..

“Koti Meka resigned from his positions as Chief Financial Officer and director of the Company. Mr. Meka's resignation as director is effective immediately, and his resignation as Chief Financial Officer is effective June 20, 2026.”

Koti Meka resigned as Chief Financial Officer at AIxCrypto Holdings, Inc..

“Koti Meka resigned from his positions as Chief Financial Officer and director of the Company. Mr. Meka's resignation as director is effective immediately, and his resignation as Chief Financial Officer is effective June 20, 2026.”

Kevin Richardson II resigned as director at AIxCrypto Holdings, Inc..

“On May 21, 2026, Kevin Richardson II notified AIxCrypto Holdings, Inc.'s (the "Company") board of directors (the "Board") of his resignation from the positions of Co-Chief Executive Officer and director of the Company, effective immediately.”

Kevin Richardson II resigned as Co-Chief Executive Officer at AIxCrypto Holdings, Inc..

“On May 21, 2026, Kevin Richardson II notified AIxCrypto Holdings, Inc.'s (the "Company") board of directors (the "Board") of his resignation from the positions of Co-Chief Executive Officer and director of the Company, effective immediately.”

AIxCrypto Holdings, Inc. entered into Note Purchase Agreement with CABG ACQUISITION CORP. valued at $100,000 (effective 2026-05-12).

“On May 12, 2026, the AIxCrypto Holdings, Inc., a Delaware corporation (the “Company”), entered into a note purchase agreement (the “Note Purchase Agreement”) with CABG ACQUISITION CORP. (“Buyer”), pursuant to which the Company agreed to sell, assign, and transfer to the Buyer, all of the Company’s right, title, and interest in the Note Package”

AIxCrypto Holdings, Inc. amended Amended and Restated Securities Purchase Agreement with GOLD KING ARTHUR HOLDING LIMITED and Faraday Future Intelligent Electric Inc. valued at $12 million (effective 2026-04-14).

“On April 14, 2026 (the "Signing Date"), GKA and FFAI entered into an Amended and Restated Securities Purchase Agreement (the "A&R Purchase Agreement"”

AIxCrypto Holdings, Inc. amended Second Entrustment Investment Amendment Agreement with GOLD KING ARTHUR HOLDING LIMITED and Song Wang (effective 2026-04-10).

“the Company further entered into the second amendment to the entrusted agreement (the "Second Entrustment Investment Amendment Agreement")”

AIxCrypto Holdings, Inc. amended First Entrusted Investment Amendment Agreement with GOLD KING ARTHUR HOLDING LIMITED and Song Wang (effective 2026-04-10).

“On April 10, 2026, the Company, GKA, and Song entered into the first amendment to the entrusted investment agreement (the "First Entrusted Investment Amendment Agreement")”

AIxCrypto Holdings, Inc. reported financial results for the fiscal year ended December 31, 2025.

“On March 24, 2026, the Company issued a press release announcing its financial and operational results for the fiscal year ended December 31, 2025, and an investor webcast that occurred on March 24, 2026 to discuss such results and update shareholders on general corporate developments.”

AIxCrypto Holdings, Inc. entered into Entrusted Investment Agreement with GOLD KING ARTHUR HOLDING LIMITED valued at aggregate consideration of $10,000,000 (effective 2026-01-30).

“On January 30, 2026, the Company entered into an entrusted investment agreement (the “Entrusted Investment Agreement”) with GOLD KING ARTHUR HOLDING LIMITED (“GKA”) and Song Wang (“Song"), under which the Company entrusted to GKA to manage an investment of shares ("FFAI Shares") of Class A common stock, par value $0.0001 per share ("FFAI Class A Common Stock"), of Faraday Future Intelligent Electric Inc. ("FFAI"), a Delaware corporation with its FFAI Class A Common Stock traded on The Nasdaq Stock Market LLC ("Nasdaq").”

AIxCrypto Holdings, Inc. entered into Consulting Agreement with FF Global Partners LLC valued at $100,000 per month (effective 2025-11-01).

“On January 28, 2026, AIxCrypto Holdings, Inc. (the “Company”) entered into a consulting services agreement (the “Consulting Agreement”), effective as of November 1, 2025, with FF Global Partners LLC (“Consultant”).”

AIxCrypto Holdings, Inc. engaged HTL International, LLC as its auditor.

“approved the engagement of HTL International, LLC (“HTL”) as the Company’s new independent registered public accounting firm”

AIxCrypto Holdings, Inc. dismissed Macias Gini & O'Connell LLP as its auditor.

“terminated Macias Gini & O’Connell LLP (“MGO”) as the independent registered public accounting firm of the Company”

AIxCrypto Holdings, Inc. received a nasdaq noncompliance notice notice regarding other (rules 5635(b)).

“November 18, 2025, the Company received a letter (the “Letter”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it failed to comply with Nasdaq’s shareholder approval requirements set forth in Nasdaq Listing Rule 5635(b) (the “Rule”), which requires shareholder approval prior to the issuance of securities when the issuance or potential issuance will result in a change of control of the Company, in connection with the Company’s private placement transaction (the “PIPE Financing”) that closed on September 29. 2025 (the”

AIxCrypto Holdings, Inc.: Changed corporate name from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc (effective 2025-11-14).

“On November 14, 2025, Qualigen Therapeutics, Inc. (the “Company”) filed with the State of Delaware a Certificate of Amendment to our Amended and Restated Certificate of Incorporation to change our corporate name from “Qualigen Therapeutics, Inc.” to “AIxCrypto Holdings, Inc.””

AIxCrypto Holdings, Inc. engaged Macias Gini & O’Connell LLP as its auditor.

“ctober 3, 2025, the Company’s Audit Committee approved the engagement of Macias Gini & O’Connell LLP (“MGO”) as the Company’s new independent registered public accounting firm for the final year ending December 31, 2025, and to perform”

WithumSmith+Brown, PC resigned as auditor of AIxCrypto Holdings, Inc..

“Resignation of Independent Registered Public Accounting Firm On October 1, 2025, WithumSmith+Brown, PC (“Withum”) notified the Audit Committee of the Board of Directors (the “Audit Committee”) of Qualigen Therapeutics, Inc. (the “Company”) that it had resigned as the Company’s independent registered public accounting firm, effective immediately.”

AIxCrypto Holdings, Inc. issued warrants to purchase number of shares equal to 6% of the securities sold in the Offering of warrant to Univest Securities LLC (Placement Agent) for cash fee of 5.5% of gross proceeds and issuance of warrants.

“the Company agreed to pay the Placement Agent a cash fee of 5.5% of the gross proceeds from the Offering and to issue to the Placement Agent (or its designees) warrants to purchase that number of shares of Common Stock equal to 6% of the securities sold in the Offering, which will be exercisable immediately following”

AIxCrypto Holdings, Inc. issued 17,783 shares of preferred stock to certain investors, including Faraday Future Intelligent Electric Inc. for cash consideration of $1,000 per share.

“Preferred Stock, par value $0.001 per share (the “Series B Stock”). The purchase price of the Common Stock was $2.246 per share and the purchase price for the Series B Stock was $1,000 per share (the “Stated Value”). At the closing of the Offering (the “Closing”), the shares of Common Stock and Series B Stock were allocated among the investors so that no”

AIxCrypto Holdings, Inc. issued 337,432 shares of common stock to certain investors, including Faraday Future Intelligent Electric Inc. for cash consideration of $2.246 per share.

“Stock”) and 17,783 shares of a newly created Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Stock”). The purchase price of the Common Stock was $2.246 per share and the purchase price for the Series B Stock was $1,000 per share (the “Stated Value”). At the closing of the Offering (the “Closing”), the shares of Common Stock and”

AIxCrypto Holdings, Inc. issued $41,000,000 in cash of Common Stock and Series B Convertible Preferred Stock of preferred stock to certain investors, including Faraday Future Intelligent Electric Inc. for $2.246 per share for Common Stock and $1,000 per share for Series B Stock, paid in cash.

““Common Stock”) and shares of a newly created Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Stock”). The purchase price of the Common Stock was $2.246 per share and the purchase price for the Series B Stock was $1,000 per share (the “Stated Value”). At the closing of the Offering (the “Closing”), the shares of Common Stock and”

AIxCrypto Holdings, Inc. issued $41,000,000 in cash of Common Stock and Series B Convertible Preferred Stock of common stock to certain investors, including Faraday Future Intelligent Electric Inc. for $2.246 per share for Common Stock and $1,000 per share for Series B Stock, paid in cash.

““Common Stock”) and shares of a newly created Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Stock”). The purchase price of the Common Stock was $2.246 per share and the purchase price for the Series B Stock was $1,000 per share (the “Stated Value”). At the closing of the Offering (the “Closing”), the shares of Common Stock and”

AIxCrypto Holdings, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“September 4, 2025, Qualigen Therapeutics, Inc. (the “Company”) received a written decision (the “Decision Letter”) from the Nasdaq Hearings Panel (the “Panel”) in response to the Company’s August 19, 2025 update and request for a compliance determination with respect to the Panel’s July 24, 2025 decision, as amended. As previously disclosed, on July 24, 2025, the Panel granted the Company an exception to remain listed on The Nasdaq Capital Market, conditioned on demonstrating compliance with Nasdaq Listing Rule 5550(b)(1) (the “Equity Rule”), which requires companies to maintain stockholders’”

AIxCrypto Holdings, Inc. amended loan of $4,451,462.18 with Marizyme, Inc. at 18% per annum maturing August 21, 2026.

“The Amended Note has a principal balance of $4,451,462.18, which represents (i) the outstanding balance of the Prior Note, (ii) accrued and unpaid interest thereon, and (iii) an additional advance of $216,000 made by the Company to Marizyme on the date of the Amended Note. The Amended Note bears interest at a rate of 18% per annum, with all accrued interest and the full principal balance due in a single balloon payment on August 21, 2026 (subject to earlier demand upon an event of default).”

AIxCrypto Holdings, Inc.: Company filed Second Amended and Restated Certificate of Designation for Series A-3 Preferred Stock (effective 2025-07-28).

“On July 28, 2025, in connection with the private placement described under Item 1.01 of this Current Report on Form 8-K, the Company filed a Second Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series A-3 Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware.”

AIxCrypto Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“July 24, 2025, the Company received a follow-up communication from the Office of the General Counsel of Nasdaq confirming that Nasdaq had granted the Company’s request for an extension to regain compliance. Nasdaq acknowledged that: The Company timely filed its Quarterly Report on Form 10-Q on or before the required deadline of July 21, 2025; The Company has demonstrated compliance with the Equity Rule on a pro forma basis following the closing of a $4.5 million private placement of Series A-3 Preferred Stock, before customary fees and expenses; and The Company submitted a compliance plan outl”

AIxCrypto Holdings, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“May 19, 2025, Qualigen Therapeutics, Inc. (the “Company”) received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on May 19, 2025 (the “Notice”). The Notice indicated that the Nasdaq Hearings Panel (the “Panel”) will consider the Company’s failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 as an additional basis for delisting the Company’s securities from The Nasdaq Stock Market . This matter serves as an additional deficiency under Nasdaq Listing Rule 5250(c)(1), which require”

AIxCrypto Holdings, Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)).

“April 24, 2025, the Company received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the Company is delinquent in filing the 2024 Form 10-K, the Company no longer complies with Nasdaq Listing Rule 5250(c) (the “Listing Rule”), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the SEC. Therefore, in line with the Panel Monitor’s decision, the Company’s securities will be delisted from Nasdaq. If the Company does not request an appeal of this decision by May 1, 2025, trading of the C”

Graydon Bensler was appointed as independent director at AIxCrypto Holdings, Inc..

“On November 7, 2024, the Board of Directors (the “Board”) appointed Graydon Bensler as an independent member of the Board, effective immediately”

AIxCrypto Holdings, Inc.: Effect a 1-for-50 reverse stock split of common stock (effective 2024-11-05).

“On October 28, 2024, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the “Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding Common Stock, effective November 5, 2024 at 12:01 a.m., Eastern Time (the “Effective Time”).”

Braeden Lichti was appointed as Independent Director at AIxCrypto Holdings, Inc..

“On October 8, 2024, the Board of Directors (the “Board”) appointed Braeden Lichti as an independent member of the Board, effective immediately, and approved the Director Agreement, attached hereto as Exhibit 10.1.”

Matt Korenberg resigned as Independent Director and Chairman of Audit Committee at AIxCrypto Holdings, Inc..

“On October 3, 2024, Mr. Matt Korenberg, independent member and chairman of the audit committee of the board of directors (the “Board”) of Qualigen Therapeutics, Inc. (the “Company”), tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.”

Kevin Richardson II was appointed as Director at AIxCrypto Holdings, Inc..

“as well as a member of the board of directors of the Company”

Kevin Richardson II was appointed as Interim Chief Executive Officer and Interim Chief Financial Officer at AIxCrypto Holdings, Inc..

“the Board of Directors appointed Kevin Richardson II as the Interim Chief Executive Officer and Interim Chief Financial Officer, as well as a member of the board of directors of the Company (the “Interim CEO and CFO”), effective immediately.”

Campbell Becher was appointed as President at AIxCrypto Holdings, Inc..

“the board of directors (the “Board”) appointed Campbell Becher as President of the Company, effective immediately.”

Christopher Lotz resigned as Chief Financial Officer at AIxCrypto Holdings, Inc..

“Mr. Christopher Lotz, Chief Financial Officer of the Company, also tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.”

Michael Poirier resigned as Chief Executive Officer and Chairman at AIxCrypto Holdings, Inc..

“Mr. Michael Poirier, Chief Executive Officer and Chairman of the board of directors of Qualigen Therapeutics, Inc. (the “Company”), tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.”

Cody Price was appointed as Director at AIxCrypto Holdings, Inc..

“On July 5, 2024, the Company’s Board of Directors appointed Campbell Becher, Robert Lim and Cody Price to serve as directors on the Board effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.”

Robert Lim was appointed as Director at AIxCrypto Holdings, Inc..

“On July 5, 2024, the Company’s Board of Directors appointed Campbell Becher, Robert Lim and Cody Price to serve as directors on the Board effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.”

Campbell Becher was appointed as Director at AIxCrypto Holdings, Inc..

“On July 5, 2024, the Company’s Board of Directors appointed Campbell Becher, Robert Lim and Cody Price to serve as directors on the Board effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.”

Ira Ritter resigned as Director at AIxCrypto Holdings, Inc..

“On July 5, 2024, Richard David, Sidney Emery, Kurt Kruger and Ira Ritter each resigned from his respective position as a member of the Company’s Board of Directors effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.”

Kurt Kruger resigned as Director at AIxCrypto Holdings, Inc..

“On July 5, 2024, Richard David, Sidney Emery, Kurt Kruger and Ira Ritter each resigned from his respective position as a member of the Company’s Board of Directors effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.”

Sidney Emery resigned as Director at AIxCrypto Holdings, Inc..

“On July 5, 2024, Richard David, Sidney Emery, Kurt Kruger and Ira Ritter each resigned from his respective position as a member of the Company’s Board of Directors effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.”

Richard David resigned as Director at AIxCrypto Holdings, Inc..

“On July 5, 2024, Richard David, Sidney Emery, Kurt Kruger and Ira Ritter each resigned from his respective position as a member of the Company’s Board of Directors effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement, which occurred on July 12, 2024.”

Cody Price was appointed as Director at AIxCrypto Holdings, Inc..

“On July 5, 2024, the Company’s Board of Directors appointed Campbell Becher, Robert Lim and Cody Price to serve as directors on the Board effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement.”

Robert Lim was appointed as Director at AIxCrypto Holdings, Inc..

“On July 5, 2024, the Company’s Board of Directors appointed Campbell Becher, Robert Lim and Cody Price to serve as directors on the Board effective upon the Company’s receipt of the $2,000,000 pursuant to the Agreement.”